Assessing Novel Drugs and Radiation Technology in the Chemoradiation of Oropharyngeal Cancer

Assessing Novel Drugs and Radiation Technology in the Chemoradiation of Oropharyngeal Cancer

Integrating immunotherapy, proton therapy and biological dose escalation into the definitive chemoradiation of oropharyngeal cancer poses several challenges. Reliable and reproducible data must be obtained in a timely fashion. However, despite recent international radiotherapy contouring guidelines,...

Full description

Bibliographic Details
Main Authors: Agostino Cristaudo, Mitchell Hickman, Charles Fong, Paul Sanghera, Andrew Hartley
Format: Article
Language:English
Published: MDPI AG 2018-06-01
Series:Medicines
Subjects:
clinical target volume (CTV)
mucositis
organ at risk (OAR)
intensity modulated proton therapy (IMPT)
PET/CT
Online Access:http://www.mdpi.com/2305-6320/5/3/65

Internet

http://www.mdpi.com/2305-6320/5/3/65

Similar Items